Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000858458 | SCV000283529 | benign | Hereditary hemorrhagic telangiectasia | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000233208 | SCV000477359 | likely benign | Telangiectasia, hereditary hemorrhagic, type 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001640379 | SCV001859221 | benign | not provided | 2019-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399807 | SCV002707838 | benign | Cardiovascular phenotype | 2015-05-22 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003907846 | SCV004719360 | likely benign | ENG-related disorder | 2019-03-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |